148 related articles for article (PubMed ID: 32061715)
1. Tauroursodeoxycholic acid attenuates cisplatin-induced hearing loss in rats.
Lee CH; Park SS; Lee DH; Lee SM; Kim MY; Choi BY; Kim SY
Neurosci Lett; 2020 Mar; 722():134838. PubMed ID: 32061715
[TBL] [Abstract][Full Text] [Related]
2. Otoprotective Effects of Zingerone on Cisplatin-Induced Ototoxicity.
Lee CH; Lee DH; Lee SM; Kim ASY
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429117
[TBL] [Abstract][Full Text] [Related]
3. Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss.
Lee CH; Kim KW; Lee SM; Kim SY
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374326
[TBL] [Abstract][Full Text] [Related]
4. Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum.
Wen Y; Zong S; Liu T; Du P; Li H; Xiao H
Toxicology; 2021 Apr; 453():152736. PubMed ID: 33631298
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic Reticulum Stress Is Involved in Cochlear Cell Apoptosis in a Cisplatin-Induced Ototoxicity Rat Model.
Zong S; Liu T; Wan F; Chen P; Luo P; Xiao H
Audiol Neurootol; 2017; 22(3):160-168. PubMed ID: 29049998
[TBL] [Abstract][Full Text] [Related]
6. Tauroursodeoxycholic acid prevents hearing loss and hair cell death in Cdh23(erl/erl) mice.
Hu J; Xu M; Yuan J; Li B; Entenman S; Yu H; Zheng QY
Neuroscience; 2016 Mar; 316():311-20. PubMed ID: 26748055
[TBL] [Abstract][Full Text] [Related]
7. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
8. The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection.
Campbell KC; Meech RP; Rybak LP; Hughes LF
J Am Acad Audiol; 2003 Apr; 14(3):144-56. PubMed ID: 12859139
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of HSP60 expression in the postnatal rat cochlea and rats with drug-induced hearing loss.
Tian K; Song Y; Zhou K; Yue B; Qiu Y; Sun F; Wang R; Zha D; Qiu J
Cell Stress Chaperones; 2018 Nov; 23(6):1311-1317. PubMed ID: 30196524
[TBL] [Abstract][Full Text] [Related]
10. Tauroursodeoxycholic acid attenuates gentamicin-induced cochlear hair cell death in vitro.
Jia Z; He Q; Shan C; Li F
Toxicol Lett; 2018 Sep; 294():20-26. PubMed ID: 29751043
[TBL] [Abstract][Full Text] [Related]
11. Allicin protects auditory hair cells and spiral ganglion neurons from cisplatin - Induced apoptosis.
Wu X; Li X; Song Y; Li H; Bai X; Liu W; Han Y; Xu L; Li J; Zhang D; Wang H; Fan Z
Neuropharmacology; 2017 Apr; 116():429-440. PubMed ID: 28062185
[TBL] [Abstract][Full Text] [Related]
12. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
[TBL] [Abstract][Full Text] [Related]
13. Lovastatin protects against cisplatin-induced hearing loss in mice.
Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
[TBL] [Abstract][Full Text] [Related]
15. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.
Bielefeld EC
Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622
[TBL] [Abstract][Full Text] [Related]
16. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
17. Effect of Folic Acid on Cisplatin-Induced Ototoxicity: A Functional and Morphological Study.
Tanyeli TT; Karadaş H; Akyıldız İ; Gökdoğan O; Sönmez Ç; Çavuş ME; Kaptan Z; Uzunkulaoğlu H; Arslan N; Zeybek ND
J Int Adv Otol; 2019 Aug; 15(2):237-246. PubMed ID: 31347504
[TBL] [Abstract][Full Text] [Related]
18. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.
Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J
Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092
[TBL] [Abstract][Full Text] [Related]
19. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
Jamesdaniel S; Rathinam R; Neumann WL
Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression.
Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ
Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
